Status:
COMPLETED
Role of CXCR2 Ligands/CXCR2 Biological Axis in Pancreatic Cancer
Lead Sponsor:
Mayo Clinic
Conditions:
Chronic Pancreatitis
Pancreatic Cancer
Eligibility:
All Genders
18-90 years
Brief Summary
The investigators hypothesize that the CXCR2 ligands/CXCR2 biological axis plays an important role in promoting angiogenesis in PC; and that the genetic changes and the microenvironment of the tumor r...
Eligibility Criteria
Inclusion
- Normal subjects - No documented clinical history of pancreatic diseases supported by at least 1 negative imaging test. (EUS, Ct scan or MRI)
- Chronic pancreatitis - Documented diagnosis of moderate to advanced chronic supported bpancreatitisy at least 1 positive imaging test. (EUS, Ct scan or MRI)
- Pancreatic Cancer - Documented tissue diagnosis (or clinical suspicion) of Pancreatic Cancer.
Exclusion
- Exclusion criteria will include age younger than 18 yrs, pregnancy, previous pancreatic or gastric resection, and inability to tolerate routine endoscopy with conscious sedation
Key Trial Info
Start Date :
May 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2011
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT00851955
Start Date
May 1 2007
End Date
November 1 2011
Last Update
January 12 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Jacksonville, Florida, United States, 32224